Meltem Kursun

Dr. Meltem Kursun

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2023 in Egyptian Journal of Neurosurgery
Verified
Journal Article
Open access
PDF file
EBERHAN BIYIKLI
ERHAN BIYIKLI
MKMeltem Kursun
Meltem Kursun
DADogukan Altuntas
Dogukan Altuntas
YBYasar Bayri
Yasar Bayri
FBFeyyaz Baltacioglu
Feyyaz Baltacioglu
Background: To investigate the imaging findings and clinical features of multinodular and vacuolating neuronal tumor (MVNT). Methods: We retrospectively sought for cases that have suspicious imaging findings for MVNT through the hospital information system. The patients’ demographics and clinical symptoms were extracted. All available images were re-examined. Results: Headache was the most common complaint (n = 7). Other complaints included seizure, stroke-like symptoms and numbness. Conventional MRI revealed that all lesions consisted of tiny, sharply marginated, round or ovoid nodules following the gyral contour. These nodules were hyperintense on T2 and FLAIR WI, hypointense on T1 WI. All lesions were characterized by a lack of enhancement and diffusion restriction. Mass effect and peripheral edema were not observed. MVNT presented as an incidental finding in one case who complained gynecomastia and had pituitary adenoma on pituitary MRI. All lesions were supratentorial—mostly on the right side (10/11)—and located in subcortical white matter. Follow-up MRI was available for 11 patients with a mean of 14.8 months (3–40 months). No change in lesion size and morphology was observed in these follow-up images. Conclusions: Radiological and clinical follow-up data suggest MVNT may exhibit indolent behavior. If asymptomatic, patients can be followed by imaging alone. Surgery should be considered for symptomatic patients.

11 April 2025 in Turkish Journal of Surgery
Verified
Journal Article
Open access
AAAhmet Akmercan
Ahmet Akmercan
TUTevfik Kıvılcım Uprak
Tevfik Kıvılcım Uprak
Onur BuğdaycıOnur Buğdaycı
Onur Buğdaycı
MKMeltem Kursun
Meltem Kursun
AAAli Emre Atıcı
Ali Emre Atıcı
Computed tomography defined body composition may predict postoperative outcomes and prognosis following gastric cancer surgery - Turkish Journal of Surgery

9 July 2024 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
KAKerem Abacar
Kerem Abacar
SOSeyma Colakoglu Ozkaya
Seyma Colakoglu Ozkaya
EBERHAN BIYIKLI
ERHAN BIYIKLI
Onur BuğdaycıOnur Buğdaycı
Onur Buğdaycı
MKMeltem Kursun
Meltem Kursun
PAPamir Atagündüz
Pamir Atagündüz

29 May 2023 in Turkish Journal of Parasitology
Verified
Journal Article
Closed access
BÇBüşra Betül Özmen Çapın
Büşra Betül Özmen Çapın
BCBarış Can
Barış Can
MKMeltem Kursun
Meltem Kursun
CCCanan Cimşit
Canan Cimşit
AKAyşegül Karahasan
Ayşegül Karahasan
Cystic echinococcosis (CE), caused by the larval stage of Echinococcus granulosus sensu latu, is one of the neglected zoonotic infectious diseases and Türkiye is among the endemic countries. This study was designed to analyze serology results for patients who were diagnosed as CE by clinical symptoms and radiological methods over a three-year period. Sera were analyzed for Anti-E. granulosus IgG by a chemiluminescence immunoassay (CLIA) (HYDATIDOSIS VIRCLIA® IgG MONOTEST, Vircell) using the VIRCLIA® (CLIA; Vircell, Granada, Spain) and results processed by the dedicated software. Cut-off for a positive test was ≥1.1 index value. Echinococcal cysts were detected based on ultrasonography, computed tomography, and magnetic resonance imaging. A total of 244 sera were analyzed from 109 patients, during three-year-period from January 2018 to December 2020. Anti-E. granulosus IgG was ordered twice in 89 patients, three times in 15 patients, four times in four patients, and five times in one patient. CLIA test was positive among 41 of 109 (37.6%) patients in whom 32 (76%) had only hepatic involvement, whereas in 5 (12%) hepatic and pulmonary involvement were coexisted. The mean age of seropositive patients was 39.8 (6-75±2.72) and 61.9% of them (n=26) were female. Time intervals between sequential test orders varied from 1 day to 33 months. Eight seropositive patients turned out to be negative, and one of 66 seronegative patients became seropositive. Positive test results were converted to negative in the case of therapy or cyst inactivity. We may conclude that CLIA could be used as a complementary tool for CE patient follow-up.

31 May 2024 in Marmara Medical Journal
Verified
Journal Article
Open access
PDF file
BKBeyza Nur Kuzan
Beyza Nur Kuzan
NANargiz Majidova Altuntash
Nargiz Majidova Altuntash
CICan Ilgin
Can Ilgin
HAHulya Arslan
Hulya Arslan
MKMeltem Kursun
Meltem Kursun
HKHandan Kaya
Handan Kaya
Objective: Breast cancer is the most common and deadly female cancer. In breast cancer cases, survival is closely related to muscle mass, which is one of the components of body composition. Our aim was to investigate the usefulness of computed-tomography (CT)- based pectoral muscle measurements in detecting sarcopenia in patients with non-metastatic breast cancer and the relationship of these measurements with survival. Patients and Methods: Our study included 62 adult female breast cancer cases diagnosed with breast cancer between January 2012 and January 2018 and without metastasis in positron emission tomography/CT (PET/CT) examination obtained for pre-treatment staging. To evaluate sarcopenia, skeletal muscle index (SMI) and pectoral muscle index (PMI) were calculated by measuring pectoral muscle area and skeletal muscle area at L3 vertebra level on PET/CT images. Results: Deceased patients were significantly older (Median=73.90, IQR=27.04) than surviving patients (Median=54.60, IQR=13.37, p=0.025) and were diagnosed with cancer later in life (Median=63.92 IQR=30.16’ vs. Median=47.51 IQR=15.0, p=0.030). When the threshold of 31 cm2/m2 was selected, there was a statistically significant difference in survival between sarcopenic and non-sarcopenic groups (p=0.031). Conclusion: In conclusion, the presence of sarcopenia in female breast cancer cases is a parameter that affects survival and can be measured using radiological imaging methods. In addition to the measurements accepted in the literature regarding sarcopenia, pectoral muscle measurements can be chosen as an alternative method in the diagnosis of sarcopenia.

2 November 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
DYDuzgun Yildirim
Duzgun Yildirim
DSDeniz Esin Tekcan Sanli
Deniz Esin Tekcan Sanli
MKMeltem Kursun
Meltem Kursun
BGBurcu Bektas Gunes
Burcu Bektas Gunes
AAAytug Altundag
Aytug Altundag
EYEnes Yerdes
Enes Yerdes
Background/Objectives: Cytologically indeterminate thyroid nodules (Bethesda III–IV) remain a diagnostic challenge. We evaluated the TRAICK (version 1.9.4; TRAICK, Istanbul, Türkiye) artificial intelligence (AI) system, which generates an American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) category and an imaging-derived Bethesda-like risk category from gray-scale ultrasound images. Methods: This retrospective proof-of-concept study included 52 surgically resected nodules with Bethesda III (n = 29) or IV (n = 23) cytology, with histopathology of the index nodule as the reference standard. The two TRAICK outputs were analyzed separately, and the ACR TI-RADS output was compared with two radiologists using the McNemar and DeLong tests. Results: Twenty-three nodules (44.2%) were malignant on index-nodule histopathology. The TRAICK ACR TI-RADS output had an accuracy of 71.2% (95% CI 57.7–81.7) and an area under the ROC curve (AUC) of 0.762 (0.640–0.884). Its AUC did not differ significantly from that of Radiologist 1 (0.762 vs. 0.777, p = 0.783); specificity was higher (65.5% vs. 37.9%, p = 0.021), whereas sensitivity was lower without a statistically significant difference (78.3% vs. 91.3%, p = 0.250). Compared with Radiologist 2, the TRAICK ACR TI-RADS output had higher accuracy (71.2% vs. 51.9%, p = 0.013), specificity (65.5% vs. 24.1%, p < 0.001), and AUC (0.762 vs. 0.629, p = 0.042). The Bethesda-like output had an AUC of 0.822 (0.707–0.938), with a sensitivity of 60.9% and specificity of 86.2% at the V–VI threshold. In sensitivity analyses, the AUC of the ACR TI-RADS output did not differ significantly from that of Radiologist 1, whereas its AUC advantage over Radiologist 2 was not statistically significant when low-risk neoplasms were classified as malignant. Conclusions: In this small, selected surgical cohort, the TRAICK ACR TI-RADS output showed discrimination that did not differ significantly from that of the more accurate of two experienced radiologists, with higher specificity, and its Bethesda-like output showed promising discrimination. These findings support further study of TRAICK as a complementary aid for preoperative decision-making; independent prospective validation is needed.